logo

For the Inventor, By the Inventor

Waltham, MA, United States of America

Syntonix Pharmaceuticals, Inc.

Calculating rank
USPTO Granted Patents = 14

% Expired Patents = 28.6


Forward Citations = 844

Loading Chart...
Loading Chart...

17 inventors (with patents filed for the assignee):

goldMedal Robert T Peters (10 out of 63 patents)

silverMedal Alan J Bitonti (10 out of 43 patents)

bronzeMedal Adam Robert Mezo (7 out of 24 patents)

4.  Daniel S Rivera (5 out of 11 patents)

5.  Susan C Low (5 out of 21 patents)

6.  Kevin McDonnell (3 out of 32 patents)

7.  James Stattel (3 out of 3 patents)

8.  Christopher TenHoor (2 out of 14 patents)

9.  Robert Charles Ladner (2 out of 107 patents)

10.  Jennifer A Dumont (2 out of 18 patents)

11.  Aaron Sato (2 out of 80 patents)

12.  Arumugam Muruganandam (2 out of 10 patents)

13.  Liming Liu (2 out of 3 patents)

14.  Clive R Wood (2 out of 37 patents)

15.  Malini Viswanathan (1 out of 20 patents)


14 patents:

1. 8815246 - Fc receptor binding proteins (2014-08-26),
2. 8449884 - Clotting factor-fc chimeric proteins to treat hemophilia (2013-05-28),
3. 8329182 - Immunoglobulin chimeric monomer-dimer hybrids (2012-12-11),
4. 8293707 - Heterodimeric follicle stimulating hormone-Fc (FSH-Fc) fusion proteins for increasing FSH activity (2012-10-23),
5. 8273351 - Fc receptor binding proteins (2012-09-25),
6. 8101186 - Peptides that block the binding of IgG to FcRn (2012-01-24),
7. 8021880 - PC5 as a factor IX propeptide processing enzyme (2011-09-20),
8. 7862820 - Immunoglobulin chimeric monomer-dimer hybrids (2011-01-04),
9. 7820162 - Methods for chemically synthesizing immunoglobulin chimeric proteins (2010-10-26),
10. 7795400 - PC5 as a factor IX propeptide processing enzyme (2010-09-14),
11. 7566565 - PC5 as a factor IX propeptide processing enzyme (2009-07-28),
12. 7404956 - Immunoglobulin chimeric monomer-dimer hybrids (2008-07-29),
13. 7381408 - Methods for chemically synthesizing immunoglobulin chimeric proteins (2008-06-03),
14. 7348004 - Immunoglobulin chimeric monomer-dimer hybrids (2008-03-25),
Company Overview
Syntonix Pharmaceuticals, Inc. is a biotechnology company based in Waltham, MA, specializing in the development of innovative therapeutic solutions. The organization focuses on advancing drug delivery technologies, particularly in the realm of biologics and monoclonal antibodies. Syntonix is dedicated to enhancing the efficacy and safety of treatments for various diseases, leveraging its proprietary platform to create novel formulations that improve patient outcomes. The company is committed to research and development, aiming to address unmet medical needs through its cutting-edge technologies.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

14 Patents

#102 in Waltham, MA

#1,364 in Massachusetts

#22,344 in US

#42,312 in the World

Waltham, MA (US)
Waltham, MA, United States of America

Syntonix Pharmaceuticals, Inc.

Forward Citations = 844

17 inventors:

goldMedal Robert T Peters (10 out of 63 patents)

silverMedal Alan J Bitonti (10 out of 43 patents)

bronzeMedal Adam Robert Mezo (7 out of 24 patents)

4.  Daniel S Rivera (5 out of 11 patents)

5.  Susan C Low (5 out of 21 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Syntonix Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/syntonix-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…